Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announces FDA clearance of the new ...

Broker UBS warns that rival Envoy Medical may steal a march on Cochlear in the emerging Totally Implantable Cochlear Implant ...

Summer is a season for social events, backyard barbecues, family vacations, and long conversations with friends. But for the more than 37 million Americans1 with hearing loss, these moments can feel ...

The S&P/ASX Healthcare Index is showing signs of recovery, rising 13.31% in June 2026 and up so far in July after hefty falls ...

Yagnik's condition is a rare case of sensorineural hearing loss triggered by a sudden viral attack after a flight in 2024, leaving her unable to hear and record songs.

The global hearing implant systems market continues to experience steady growth as advances in auditory technologies, ...

For most people, the ability to enjoy the aroma of freshly brewed coffee, to savour a favourite meal or to notice the scent ...

The high sensitivity of MRI in the depiction of plaques in the brain and spinal cord has made this technique the most important paraclinical tool for the diagnosis of multiple sclerosis (MS). MRI ...

For most people, blurry vision, hearing loss, and balance problems are different health problems. It's easy to think that ...

What is the current share price of Cochlear Limited (COH)? Cochlear Limited's (COH) current share price is $119.19. This constitutes a price movement of 3.63% when compared to the share price 7 days ...

Structural imaging based on magnetic resonance is an integral part of the clinical assessment of patients with suspected Alzheimer dementia. Prospective data on the natural history of change in ...

Abstract: Cochlear implants (CIs) have become remarkably successful in restoring the hearing abilities of profoundly hearing-impaired or deaf people. Although in most cases the understanding of ...